Skip to main content

Risk for Heart Failure Higher in Young Adult Cancer Survivors

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

WEDNESDAY, June 7, 2023 -- Young adult (YA) cancer survivors, especially those diagnosed with leukemia or those treated with anthracycline chemotherapy, face an increased risk for heart failure, according to a research letter published online May 16 in JACC: CardioOncology.

Elizabeth Hibler, Ph.D., from Northwestern University in Chicago, and colleagues used electronic health records to examine associations between cancer diagnosis (2000 to 2019) and risk for heart failure among 12,879 YA cancer survivors (18 to 39 years).

The researchers found that the five-year incidence of heart failure was higher among YA cancer survivors with anthracycline exposure (738 individuals) compared with those without exposure (4.0 versus 1.3 percent; hazard ratio [HR], 2.6; 95 percent confidence interval [CI], 1.6 to 4.9). When adjusting for competing risk for death, the risk was similar (HR, 2.4; 95 percent CI, 1.5 to 3.7). When adjusting for age, sex, race-ethnicity, history of hypertension or cardiovascular disease, secondary cancer diagnosis, and additional covariates, the risk estimate was similar. The five-year cumulative incidence of heart failure was significantly highest for leukemia survivors but was also elevated for kidney, lymphoma, bone, and breast cancer survivors versus the survivors of other cancer types.

"We often think about heart failure as a disease people get when they are old, but this work highlights that this is also a short-term risk for patients who survive cancer," senior author Sadiya Khan, M.D., of Northwestern Medicine, said in a statement. "It raises awareness for patients and clinicians to monitor symptoms and consider strategies for prevention."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Lower Prevalence of Employment Seen for Survivors of Childhood Cancer

FRIDAY, May 10, 2024 -- Adult survivors of childhood cancer have declines in employment and increases in health-related unemployment compared with the general population...

Implantable Continuous Flow Device Feasible for Small Children With Severe Systolic Heart Failure

FRIDAY, May 10, 2024 -- The Jarvik 2015 left ventricular assist device (LVAD) seems promising as an implantable continuous flow device for small children with severe systolic...

Symptom Burden Prevalent in Childhood Cancer Survivors

THURSDAY, May 9, 2024 -- Symptom burden is prevalent among young childhood cancer survivors, with caregiver anxiety and greater neighborhood deprivation associated with greater...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.